|
| 37978284 | The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial. | Nat Med | 2024 |
| 37944912 | Pediatric low-grade glioma: State-of-the-art and ongoing challenges. | Neuro Oncol | 2024 |
| 37978284 | The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial. | Nat Med | 2024 |
| 37944912 | Pediatric low-grade glioma: State-of-the-art and ongoing challenges. | Neuro Oncol | 2024 |
| 36124689 | Response assessment in pediatric craniopharyngioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) Working Group. | Neuro Oncol | 2023 |
| 36124689 | Response assessment in pediatric craniopharyngioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) Working Group. | Neuro Oncol | 2023 |
| 37943476 | Recent Advances in Pediatric Medulloblastoma. | Curr Neurol Neurosci Rep | 2023 |
| 37733309 | Dabrafenib plus Trametinib in Pediatric Glioma with <i>BRAF</i> V600 Mutations. | N Engl J Med | 2023 |
| 37643378 | Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory <i>BRAF</i> V600-Mutant Pediatric High-Grade Glioma. | J Clin Oncol | 2023 |
| 37203791 | Optical genome mapping identifies a novel pediatric embryonal tumor with a ZNF532::NUTM1 fusion. | J Pathol | 2023 |
| 37010875 | Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma. | Neuro Oncol | 2023 |
| 37046110 | First-in-human sonodynamic therapy with ALA for pediatric diffuse intrinsic pontine glioma: a phase 1/2 study using low-intensity focused ultrasound : Technical communication. | J Neurooncol | 2023 |
| 36609372 | Surveillance imaging and early surgical intervention for improved CNS tumor outcomes in children with Li-Fraumeni syndrome: Children's National Hospital experience and literature review. | J Neurosurg Pediatr | 2023 |
| 37171383 | Addendum: Histological and molecular analysis of a progressive diffuse intrinsic pontine glioma and synchronous metastatic lesions: a case report. | Oncotarget | 2023 |
| 37943476 | Recent Advances in Pediatric Medulloblastoma. | Curr Neurol Neurosci Rep | 2023 |
| 37733309 | Dabrafenib plus Trametinib in Pediatric Glioma with <i>BRAF</i> V600 Mutations. | N Engl J Med | 2023 |
| 37643378 | Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory <i>BRAF</i> V600-Mutant Pediatric High-Grade Glioma. | J Clin Oncol | 2023 |
| 37046110 | First-in-human sonodynamic therapy with ALA for pediatric diffuse intrinsic pontine glioma: a phase 1/2 study using low-intensity focused ultrasound : Technical communication. | J Neurooncol | 2023 |
| 37010875 | Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma. | Neuro Oncol | 2023 |
| 37171383 | Addendum: Histological and molecular analysis of a progressive diffuse intrinsic pontine glioma and synchronous metastatic lesions: a case report. | Oncotarget | 2023 |
| 37203791 | Optical genome mapping identifies a novel pediatric embryonal tumor with a ZNF532::NUTM1 fusion. | J Pathol | 2023 |
| 36609372 | Surveillance imaging and early surgical intervention for improved CNS tumor outcomes in children with Li-Fraumeni syndrome: Children's National Hospital experience and literature review. | J Neurosurg Pediatr | 2023 |
| 34668975 | Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry. | Neuro Oncol | 2022 |
| 35821675 | Infantile suprasellar tumor diagnosed as a pineoblastoma RB1 subgroup and treatment challenges: A pediatric SNO Molecular Tumor Board. | Neurooncol Adv | 2022 |
| 35552452 | Characteristics of children ⿤36 months of age with DIPG: A report from the international DIPG registry. | Neuro Oncol | 2022 |
| 35736214 | OLIG2 Is a Determinant for the Relapse of MYC-Amplified Medulloblastoma. | Clin Cancer Res | 2022 |
| 36068285 | Circulating tumor DNA sequencing provides comprehensive mutation profiling for pediatric central nervous system tumors. | NPJ Precis Oncol | 2022 |
| 35729337 | Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours. | Nat Rev Neurol | 2022 |
| 35788692 | MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus. | Neuro Oncol | 2022 |
| 35852795 | Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003. | Clin Cancer Res | 2022 |
| 35307742 | Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) Study. | Neuro Oncol | 2022 |
| 34668975 | Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry. | Neuro Oncol | 2022 |
| 34962573 | Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors. | Endocr Rev | 2022 |
| 35148393 | Volumetric endpoints in diffuse intrinsic pontine glioma: comparison to cross-sectional measures and outcome correlations in the International DIPG/DMG Registry. | Neuro Oncol | 2022 |
| 35196386 | Two clinically distinct cases of infant hemispheric glioma carrying ZCCHC8:ROS1 fusion and responding to entrectinib. | Neuro Oncol | 2022 |
| 35736214 | OLIG2 Is a Determinant for the Relapse of MYC-Amplified Medulloblastoma. | Clin Cancer Res | 2022 |
| 35729337 | Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours. | Nat Rev Neurol | 2022 |
| 35821675 | Infantile suprasellar tumor diagnosed as a pineoblastoma RB1 subgroup and treatment challenges: A pediatric SNO Molecular Tumor Board. | Neurooncol Adv | 2022 |
| 35788692 | MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus. | Neuro Oncol | 2022 |
| 35852795 | Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003. | Clin Cancer Res | 2022 |
| 35552452 | Characteristics of children ⿤36 months of age with DIPG: A report from the international DIPG registry. | Neuro Oncol | 2022 |
| 36068285 | Circulating tumor DNA sequencing provides comprehensive mutation profiling for pediatric central nervous system tumors. | NPJ Precis Oncol | 2022 |
| 35307742 | Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) Study. | Neuro Oncol | 2022 |
| 35148393 | Volumetric endpoints in diffuse intrinsic pontine glioma: comparison to cross-sectional measures and outcome correlations in the International DIPG/DMG Registry. | Neuro Oncol | 2022 |
| 35196386 | Two clinically distinct cases of infant hemispheric glioma carrying ZCCHC8:ROS1 fusion and responding to entrectinib. | Neuro Oncol | 2022 |
| 34962573 | Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors. | Endocr Rev | 2022 |
| 33336845 | Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1-associated optic pathway gliomas in children. | Pediatr Blood Cancer | 2021 |
| 31838937 | Cognition, ADHD Symptoms, and Functional Impairment in Children and Adolescents With Neurofibromatosis Type 1. | J Atten Disord | 2021 |
| 34292305 | Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology Group. | JAMA Oncol | 2021 |
| 34125480 | Multi-institutional analysis of treatment modalities in basal ganglia and thalamic germinoma. | Pediatr Blood Cancer | 2021 |